Participation of ATP7A in macrophage mediated oxidation of LDL

Journal of Lipid Research

Volumn 51, Issue 6, 2010, Pages 1471-1477

  Qin, Zhenyu ^a   Konaniah, Eddy S ^a   Neltner, Bonnie ^a   Nemenoff, Raphael A ^b   Hui, David Y ^a   Weintraub, Neal L ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSOLIC PHOSPHOLIPASE A2; LOW DENSITY LIPOPROTEIN RECEPTOR; MENKES PROTEIN; OLIGONUCLEOTIDE; PROTEIN SUBUNIT; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIPID OXIDATION; MACROPHAGE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TRANSCRIPTION REGULATION;

ADENOSINE TRIPHOSPHATASES; ANIMALS; ATHEROSCLEROSIS; CATION TRANSPORT PROTEINS; CELL LINE; DOWN-REGULATION; GROUP IV PHOSPHOLIPASES A2; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; MICE; OXIDATION-REDUCTION; PROTEIN TRANSPORT;

EID: 77952710232     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M003426     Document Type: Article

References (46)

1. Schaefer, M., and J. D. Gitlin. 1999. Genetic disorders of membrane transport. IV. Wilson's disease and Menkes disease. Am. J. Physiol. 276: G311-G314. (Pubitemid 29104143)
2. Lutsenko, S., et al. 2007. Function and regulation of human copper-transporting ATPases. Physiol. Rev. 87: 1011-1046. (Pubitemid 47084675)
3. La Fontaine, S., and J. F. Mercer. 2007. Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis. Arch. Biochem. Biophys. 463: 149-167. (Pubitemid 47030343)
4. Hardman, B., et al. 2004. Expression and localization of menkes and Wilson copper transporting ATPases in human placenta. Placenta. 25: 512-517. (Pubitemid 38701894)
5. Paynter, J. A., et al. 1994. Expression of the Menkes gene homologue in mouse tissues lack of effect of copper on the mRNA levels. FEBS Lett. 351: 186-190.
6. Niciu, M. J., et al. 2006. Developmental changes in the expression of ATP7A during a critical period in postnatal neurodevelopment. Neuroscience. 139: 947-964.
7. Kaler, S. G., et al. 2008. Neonatal diagnosis and treatment of Menkes disease. N. Engl. J. Med. 358: 605-614. (Pubitemid 351214287)
8. Qin, Z., et al. 2006. Essential role for the Menkes ATPase in activation of extracellular superoxide dismutase: implication for vascular oxidative stress. FASEB J. 20: 334-336. (Pubitemid 46671162)
9. Afton, S., et al. 2009. Copper egress is induced by PMA in human THP-1 cells: a potential regulator of VEGFR1. Biometals. 22: 531-53 9.
10. Andrews, E. J., W. J. White, and L. P. Bullock. 1975. Spontaneous aortic aneurysms in blotchy mice. Am. J. Pathol. 78: 199-210.
11. Chisolm III, G. M., et al. 1999. The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms. J. Biol. Chem. 274: 25959-25962. (Pubitemid 129520010)
12. Ehrenwald, E., and P. L. Fox. 1996. Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells. J. Clin. Invest. 97: 884-890. (Pubitemid 26057109)
13. Rozenberg, O., et al. 2003. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. Free Radic. Biol. Med. 34: 774-784. (Pubitemid 36288542)
14. Carr, A. C., M. R. McCall, and B. Frei. 2000. Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. Arterioscler. Thromb. Vasc. Biol. 20: 1716-1723.
15. Rydberg, E. K., et al. 2004. Hypoxia increases LDL oxidation and expression of 15-lipoxygenase-2 in human macrophages. Arterioscler. Thromb. Vasc. Biol. 24: 2040-2045.
16. Sakashita, T., et al. 1999. Essential involvement of 12-lipoxygenase in regiospecific andstereospecific oxidation of low density lipoprotein by macrophages. Eur. J. Biochem. 265: 825-831. (Pubitemid 29489016)
17. Cathcart, M. K. 2004. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24: 23-28. (Pubitemid 38082407)
18. Xu, W., et al. 2001. Low density lipoprotein receptor-related protein is required for macrophage-mediated oxidation of low density lipoprotein by 12/15-lipoxygenase. J. Biol. Chem. 276: 36454-36459. (Pubitemid 37384255)
19. Li, Q., and M. K. Cathcart. 1997. Selective inhibition of cytosolic phospholipase A2 in activated human monocytes. Regulation of superoxide anion production and low density lipoprotein oxidation. J. Biol. Chem. 272: 2404-2411. (Pubitemid 27058529)
20. Wen, Y., and D. S. Leake. 2007. Low density lipoprotein undergoes oxidation within lysosomes in cells. Circ. Res. 100: 1337-1343. (Pubitemid 46742924)
21. Fukai, T., et al. 1998. Vascular expression of extracellular superoxide dismutase in atherosclerosis. J. Clin. Invest. 101: 2101-2111 (Pubitemid 28244094)
22. Barker, K. S., T. Liu, and P. D. Rogers. 2005. Coculture of THP-1 human mononuclear cells with Candida albicans results in pronounced changes in host gene expression. J. Infect. Dis. 192: 901-912.
23. Lagoumintzis, G., et al. 2003. Pseudomonas aeruginosa slime glycolipoprotein is a potent stimulant of tumor necrosis factor alpha gene expression and activation of transcription activators nuclear factor kappa B and activator protein 1 in human monocytes. Infect. Immun. 71: 4614-4622. (Pubitemid 36919928)
24. Xu, L., et al. 2008. Activation of cytosolic phospholipase A2alpha through nitric oxide-induced S-nitrosylation. Involvement of inducible nitric-oxide synthase and cyclooxygenase-2. J. Biol. Chem. 283: 3077-3087.
25. Tay, A., et al. 1994. Isolation of promoter for cytosolic phospholipase A2 (cPLA2). Biochim. Biophys. Acta. 1217: 345-347. (Pubitemid 24113519)
26. Van Putten, V., et al. 2001. Induction of cytosolic phospholipase A2 by oncogenic Ras is mediated through the JNK and ERK pathways in rat epithelial cells. J. Biol. Chem. 276: 1226-1232. (Pubitemid 32096550)
27. Wang, J. H., et al. 2002. Induction of bacterial lipoprotein tolerance is associated with suppression of toll-like receptor 2 expression. J. Biol. Chem. 277: 36068-36075.
28. Stewart, A., et al. 2002. Enzymatic properties of human cytosolic phospholipase A(2)gamma. J. Biol. Chem. 277: 29526-29536. (Pubitemid 41079240)
29. Noor, S., et al. 2008. Activation of cytosolic phospholipase A2alpha in resident peritoneal macrophages by Listeria monocytogenes involves listeriolysin O and TLR2. J. Biol. Chem. 283: 4744-4755.
30. Pavicevic, Z., C. C. Leslie, and K. U. Malik. 2008. cPLA2 phosphorylation at serine-515 and serine-505 is required for arachidonic acid release in vascular smooth muscle cells. J. Lipid Res. 49: 724-737.
31. Girotti, M., et al. 2004. Cytosolic phospholipase A2 translocates to forming phagosomes during phagocytosis of zymosan in macrophages. J. Biol. Chem. 279: 19113-19121. (Pubitemid 38623342)
32. Kim, B. E., K. Smith, and M. J. Petris. 2003. A copper treatable Menkes disease mutation associated with defective trafficking of a functional Menkes copper ATPase. J. Med. Genet. 40: 290-295.
33. Qin, Z., et al. 2008. Role of Menkes ATPase in angiotensin II-induced hypertension: a key modulator for extracellular superoxide dismutase function. Hypertension. 52: 945-951.
34. El Meskini, R., et al. 2003. Supplying copper to the cuproenzyme peptidylglycine alpha-amidating monooxygenase. J. Biol. Chem. 278: 12278-12284. (Pubitemid 36800210)
35. Petris, M. J., D. Strausak, and J. F. Mercer. 2000. The Menkes copper transporter is required for the activation of tyrosinase. Hum. Mol. Genet. 9: 2845-2851.
36. Reddy, M. C., S. Majumdar, and E. D. Harris. 2000. Evidence for a Menkes-like protein with a nuclear targeting sequence. Biochem. J. 350: 855-863.
37. Gacheru, S., et al. 1993. Expression and accumulation of lysyl oxidase, elastin, and type I procollagen in human Menkes and mottled mouse fibroblasts. Arch. Biochem. Biophys. 301: 325-329. (Pubitemid 23214126)
38. Evans, J. H., et al. 2001. Intracellular calcium signals regulating cytosolic phospholipase A2 translocation to internal membranes. J. Biol. Chem. 276: 30150-30160. (Pubitemid 37385095)
39. Leslie, C. C. 1997. Properties and regulation of cytosolic phospholipase A2. J. Biol. Chem. 272: 16709-16712.
40. Roshak, A. K., et al. 1996. Manipulation of distinct NFkappaB proteins alters interleukin-1beta-induced human rheumatoid synovial fibroblast prostaglandin E2 formation. J. Biol. Chem. 271: 31496-31501.
41. Dronadula, N., et al. 2005. STAT-3-dependent cytosolic phospholipase A2 expression is required for thrombin-induced vascular smooth muscle cell motility. J. Biol. Chem. 280: 3112-3120. (Pubitemid 40189422)
42. Neeli, I., et al. 2004. An essential role of the Jak-2/STAT-3/cytosolic phospholipase A(2) axis in platelet-derived growth factor BB-induced vascular smooth muscle cell motility. J. Biol. Chem. 279: 46122-46128. (Pubitemid 39491606)
43. Wu, T., et al. 1994. Characterization of the promoter for the human 85 kDa cytosolic phospholipase A2 gene. Nucleic Acids Res. 22: 5093-5098.
44. Dolan-O'Keefe, M., et al. 2000. Transcriptional regulation and structural organization of the human cytosolic phospholipase A(2) gene. Am. J. Physiol. Lung Cell. Mol. Physiol. 278: L649-L657. (Pubitemid 30220025)
45. Zhao, X., et al. 2002. Cytosolic phospholipase A2 (cPLA2) regulation of human monocyte NADPH oxidase activity. cPLA2 affects translocation but not phosphorylation of p67(phox) and p47(phox). J. Biol. Chem. 277: 25385-25392.
46. Chen, C. S. 2002. Phorbol ester induces elevated oxidative activity and alkalization in a subset of lysosomes. BMC Cell Biol. 3: 21.